# Nuvectis Pharma, Inc.: Form 8-K, filed Jun 13, 2024

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: 8-K
- Filed: 2024-06-13
- Accepted by EDGAR: Jun 13, 2024, 16:09 ET
- Period: 2024-06-13
- Accession: 0001104659-24-071261
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465924071261/tm2417208d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465924071261/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465924071261/tm2417208d1_8k.htm

Filed Jun 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-071261. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.